@LucySW - I hope it's an accurate one!
A couple of things have struck me today about this system:
1. My BG is almost always moving too slowly for the Libre to show it as anything other than a horizontal arrow - is that because I low-carb? The only times I've seen any rapid-moving BG has been the three times I've eaten 'real' carb over the last week - bread, ryvita and today's Mars Celebration to correct the hypo. Did they test this at all on people who don't eat the big 5 carbs? I'm guessing they must have done, but I am starting to wonder. Come on Abbotts, come clean on your trial profile!
2. Some of the 'trueisms' of diabetes are being debunked by the evidence coming off the system - 1 tiny Mars Celebration (about 6g carb) raised my BG almost instantly (no more will I believe that chocolate is a bad hypo treatment as it isn't quick enough to hit the BG!!!). The amount it raised my BG was breath-taking - 2.2mmol - 7.3mmol if you believe the Mobile or 4.6mmol - 9.7mmol if you believe the Libre - and it stayed at the elevated level, falling very slowly by around 0.7mmol over the following 2 hours. Even the Libre managed to catch that rate of change and immediately displayed a vertical arrow. Notice that both systems believe my BG changed by the same amount - just a different starting point - interesting! No more can well-meaning DSNs tell me I have to use 15g of quick-acting carb followed by 15g of long-acting carb to correct my hypos - I've always known this is rubbish, but I now have the proof in cold hard data! I think this is going to be very challenging for DSNs, GPs and consultants alike - it is truly user-empowering - and I don't think they're going to like it!
3. Apidra rapid-acting should be done under the Trade Description Act - it is NOT rapid!!! My evidence from the past nearly week is showing me that to make it really work with the pattern of the food, I need to take it about 30 - 45 minutes before eating! I have changed the timing of my morning Apidra and have gone from a 'stormy Atlantic' to a 'duck pond' post breakfast profile. How are the big drug companies going to react to our more detailed knowledge of their products? Will they step up to the mark or will they try to rubbish the Libre system? Time will tell.
Whatever its foibles, this system has the potential to be truly game changing for diabetes.
Smidge